Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium.
Goossens ME, Buntinx F, Joniau S, Ackaert K, Ameye F, Billiet I, Braeckman J, Breugelmans A, Darras J, Dilen K, Goeman L, Kellen E, Tombal B, Van Bruwaene S, Van Cleyenbreuge B, Van der Aa F, Vekemans K, Van Poppel H, Zeegers MP.
Goossens ME, et al. Among authors: goeman l.
BMC Urol. 2012 Mar 21;12:8. doi: 10.1186/1471-2490-12-8.
BMC Urol. 2012.
PMID: 22436453
Free PMC article.
Clinical Trial.